calendar
2,159 catalysts · 3,728 phase readout · 2,105 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
next 91 dayslessmore
MonWedFri
2,159 catalysts · 3,728 phase readout · 2,105 8k filing · 276 earnings · 172 phase 2 completion · 138 grant · 133 drug shortage
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 4.02
Items: 5.02
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 3.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 9.01
Items: 1.01, 2.03, 3.01, 3.03, 9.01
Items: 2.05, 7.01, 9.01
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 5.07, 9.01
Items: 5.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 9.01